ClinConnect ClinConnect Logo
Search / Trial NCT06554925

SEx-specific Differences in Cardiac Surgery Patients (SECS).

Launched by JENNIFER BREEL · Aug 12, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Anesthesia Sex Specific Differences Cardiac Surgery Care Pathways

ClinConnect Summary

The SECS clinical trial is looking at the differences between women and men who have heart surgery. Researchers want to understand how factors like body weight, health history, and how the body reacts to medications and blood transfusions can affect the outcomes of surgery. They will track patients' health in the short term (up to 30 days after surgery) and longer term (up to one year) to see how these factors influence recovery and overall health.

To participate in this study, you must be at least 18 years old and have undergone cardiac surgery at a specific hospital between January 1998 and June 2021. There are no other specific exclusions, which means many people may qualify. If you join the trial, you will help researchers learn important information that could improve care for future cardiac surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients \> 18 years
  • All patients who underwent cardiac surgery from 1 January 1998 in the AUMC, location VUmc, until 1 June 2021.
  • Exclusion Criteria:
  • None

About Jennifer Breel

Jennifer Breel is a dedicated clinical trial sponsor committed to advancing medical research through innovative and ethical trial design. With a focus on enhancing patient outcomes and safety, Jennifer Breel collaborates with healthcare professionals, researchers, and regulatory bodies to ensure rigorous adherence to industry standards. Her expertise encompasses a wide range of therapeutic areas, fostering the development of novel treatments that address unmet medical needs. Through a patient-centered approach, she aims to contribute to the transformative potential of clinical research, ultimately improving healthcare solutions for diverse populations.

Locations

Amsterdam, North Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Markus W Hollmann, Professor

Principal Investigator

Anesthesiology and Pain Medicine, Amsterdam Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported